BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
DNA fingerprint
,
Rapamycin
,
rs7903146
,
LEP
,
G-protein-coupled receptor binding
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Ro antibodies
Summary
General Info
Curated Studies
Most Correlated Studies
Drug target sets for approved compounds
Umbilical vein endothelial cells with ANGPT1 or TEK/TIE2 activation
Hodgkin's lymphoma cell lines treated with kinase inhibitors perifosine, givinostat and sorafenib
Naive T cells CD4+ primed with CpGA- or oxidized mtDNA-activated plasmacytoid dendritic cells
Multiple myeloma KMS11 cells prior to or after Dox-induced PRDM5 shRNA expression
Explore Curated Studies Results
Literature
Most Relevant Literature
Measurement of fetal atrioventricular intervals in pregnant women with anti-SSA/Ro antibodies.
Discovery of Anti-SS-A Antibodies during Stroke Investigations in Young Adults: What Impact?
Concomitant Ro/SSA and La/SSB antibodies are biomarkers for the risk of venous thromboembolism and c…
Anti- SSA/Ro and Anti-SSB/ La Antibodies in Patients with Yusho].
Unilateral bamboo node of the vocal fold associated with anti-SS-A and anti-SS-B antibody.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
D1 Receptor Occupancy (RO) Following a Single Dose of PF-06412562
Autoreactive Anti-Ro/SSA IgE To Determine Primary SjögRen's Syndrome's Disease Activity
Ro 31-7453 in Treating Patients With Recurrent or Refractory Metastatic Colorectal Cancer
mFOLFOX6+Bevacizumab+PD-1 Monoclonal Antibody in Local Advanced MSS CRC
Occurrence of Antibodies Cross-reacting With Autoantigens in Primary EBV Infection
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ